Akso Health Group shares fall 5.63% in after-hours due to significant revenue growth in medical equipment distribution and expansion plans for cancer treatment centers in the US.

Akso Health Group Inc. surged 5.63% in after-hours trading, driven by significant growth in its medical device distribution business for the 2024 fiscal year and plans to expand cancer treatment center operations in the U.S., including the establishment of vaccine research facilities and radiation oncology service centers. The company's stock has seen a cumulative increase of 17.32% over the past five days.